Medicine and Dentistry
Global Disease Burden
100%
Disability Adjusted Life Years
59%
Diseases
52%
Malignant Neoplasm
34%
Mesothelioma
31%
Mortality Rate
21%
Occupational Exposure
21%
Lung Cancer
20%
Public Health
17%
Asbestos Fiber
16%
Life Expectancy
15%
Specific Mortality
13%
Non Communicable Disease
13%
Cancer Incidence
12%
Chronic Respiratory Tract Disease
12%
Cancer Mortality
11%
Ischemic Heart Disease
10%
Respiratory Tract Infection
10%
Asbestos Exposure
10%
Chronic Obstructive Pulmonary Disease
10%
Newborn Disease
10%
HIV/AIDS
9%
Prevalence
9%
Health System
9%
Cancer Registry
9%
Meta-Regression
9%
Awareness
8%
Asthma
7%
Trachea Cancer
7%
Bronchus Cancer
7%
Head
7%
Household
7%
Premature Labor
7%
Population Growth
6%
Health Care
6%
Environmental Exposure
6%
Maternal Disease
6%
Pleura Mesothelioma
6%
Exposure Assessment
6%
All Cause Mortality
6%
Latent Tuberculosis
6%
Ethinylestradiol Plus Norethisterone Acetate
6%
Health Outcomes
6%
Vitreous
6%
Cancer in Young Adults
6%
Lifespan
6%
In Silico
6%
Hazard Ratio
6%
Survival Analysis
6%
Occupational Health
6%
Pharmacology, Toxicology and Pharmaceutical Science
Global Disease Burden
82%
Diseases
46%
Asbestos-Related Diseases
36%
Malignant Neoplasm
33%
Mesothelioma
28%
Occupational Exposure
21%
Lung Cancer
20%
Mortality Rate
13%
Asbestos Fiber
12%
Cancer Incidence
12%
Chronic Respiratory Tract Disease
12%
Pleura Mesothelioma
12%
Elimination
10%
Chronic Obstructive Lung Disease
10%
Prevalence
9%
Respiratory Tract Infection
8%
Cardiovascular Disease
8%
Asthma
7%
Bronchus Cancer
7%
Trachea Cancer
7%
Newborn Disease
7%
Non Communicable Disease
7%
Ischemic Heart Disease
6%
Thrombocyte Activating Factor
6%
Carcinogen
6%
Environmental Exposure
6%
Pneumoconiosis
6%
Cohort Study
6%
Chronic Kidney Failure
6%
Focal Adhesion Kinase Inhibitor
6%
Uvomorulin
6%
microRNA
6%
Primary Culture
6%
Lead Poisoning
6%
Growth Disorder
6%
Respiratory Tract
6%
Premature Labor
6%
HIV
6%
Cancer Registry
5%
Larynx Cancer
5%
Cancer Mortality
5%
Neoplasm
5%
Biological Marker
5%
Randomized Controlled Trial
5%
Age Distribution
5%